A detailed history of Ever Source Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 6,222 shares of AZN stock, worth $417,993. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,222
Previous 6,117 1.72%
Holding current value
$417,993
Previous $477,000 1.47%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$76.67 - $87.62 $8,050 - $9,200
105 Added 1.72%
6,222 $484,000
Q2 2024

Aug 13, 2024

BUY
$66.81 - $80.83 $53,448 - $64,664
800 Added 15.05%
6,117 $477,000
Q1 2024

Jun 11, 2024

SELL
$61.03 - $69.57 $11,900 - $13,566
-195 Reduced 3.54%
5,317 $360,000
Q4 2023

Feb 09, 2024

SELL
$61.89 - $69.28 $1,856 - $2,078
-30 Reduced 0.54%
5,512 $371,000
Q3 2023

Nov 03, 2023

SELL
$64.85 - $71.7 $38,456 - $42,518
-593 Reduced 9.67%
5,542 $375,000
Q2 2023

Aug 04, 2023

SELL
$69.91 - $75.81 $35,094 - $38,056
-502 Reduced 7.56%
6,135 $439,000
Q1 2023

May 11, 2023

SELL
$63.15 - $71.6 $50,456 - $57,208
-799 Reduced 10.75%
6,637 $460,000
Q4 2022

Feb 09, 2023

SELL
$54.21 - $70.44 $82,290 - $106,927
-1,518 Reduced 16.95%
7,436 $504,000
Q3 2022

Nov 07, 2022

SELL
$53.02 - $135.75 $91,088 - $233,218
-1,718 Reduced 16.1%
8,954 $491,000
Q2 2022

Aug 01, 2022

BUY
$59.26 - $71.14 $172,802 - $207,444
2,916 Added 37.6%
10,672 $706,000
Q1 2022

May 25, 2022

BUY
$55.72 - $67.12 $267,790 - $322,578
4,806 Added 162.92%
7,756 $515,000
Q4 2021

Feb 07, 2022

BUY
$54.02 - $63.83 $159,359 - $188,298
2,950 New
2,950 $172,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.